In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series B leads to $11.5mm for device firm Core Essence Orthopaedics

Executive Summary

Core Essence Orthopaedics Inc. (devices for minimally invasive soft tissue and arthroscopic musculoskeletal repair) raised $11.5mm in its Series B financing led by Baird Venture Partners, which adds a board member. Also participating was Series A backer NewSpring Health Capital, Robin Hood Ventures, and individual investors. The funds will support commercialization activities for the company's soft tissue and skeletal repair devices. Core Essence’s 2008 Series A brought in $5mm.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies